Enasidenib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.Enasidenib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Enasidenib Nitroso Impurity 2 CAS NO: NA chemically represented as N-(4-((2-Hydroxy-2-methylpropyl)(nitroso)amino)-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)nitrous amide. Synchemia is the leading manufacturing and exporter of Enasidenib Nitroso Impurity 2 . We supply Enasidenib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142547 |
| CAS No | NA |
| Mol.F. | C21H21ClN4O2 |
| Mol.Wt. | 396.88 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142548 |
| CAS No | NA |
| Mol.F. | C33H33N5O7 |
| Mol.Wt. | 611.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142549 |
| CAS No | NA |
| Mol.F. | C13H16N6O9S2 |
| Mol.Wt. | 464.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142550 |
| CAS No | NA |
| Mol.F. | C18H28N4O6 |
| Mol.Wt. | 396.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142551 |
| CAS No | NA |
| Mol.F. | C12H14N4O |
| Mol.Wt. | 230.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142552 |
| CAS No | NA |
| Mol.F. | C24H27N3O6 |
| Mol.Wt. | 453.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142553 |
| CAS No | NA |
| Mol.F. | C24H27N3O6 |
| Mol.Wt. | 453.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142554 |
| CAS No | NA |
| Mol.F. | C22H23N3O6 |
| Mol.Wt. | 425.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142555 |
| CAS No | NA |
| Mol.F. | C24H33N3O6 |
| Mol.Wt. | 459.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142556 |
| CAS No | NA |
| Mol.F. | C26H31N3O6 |
| Mol.Wt. | 481.55g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142557 |
| CAS No | NA |
| Mol.F. | C18H13N3O4 |
| Mol.Wt. | 335.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142558 |
| CAS No | NA |
| Mol.F. | C24H27N3O6 |
| Mol.Wt. | 453.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142559 |
| CAS No | NA |
| Mol.F. | C28H35N3O6 |
| Mol.Wt. | 509.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142560 |
| CAS No | NA |
| Mol.F. | C24H27N3O7 |
| Mol.Wt. | 469.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142561 |
| CAS No | 101265-45-6 |
| Mol.F. | C13H18N2O3 |
| Mol.Wt. | 250.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142562 |
| CAS No | NA |
| Mol.F. | C14H21N3O3 |
| Mol.Wt. | 279.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |